Co Diagnostics Inc Stock Ownership - Who owns Co Diagnostics?

Insider buying vs selling

Have Co Diagnostics Inc insiders been buying or selling?
Brian Lee BrownChief Financial Officer2023-05-2326,057$1.32
Dwight H. EganChief Executive Officer2023-05-2332,103$1.32
Brian Lee BrownChief Financial Officer2023-03-203,000$1.90
Brian Lee BrownChief Financial Officer2022-11-2318,187$3.47
Dwight H. EganChief Executive Officer2022-11-2332,110$3.47

1 of 1

CODX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CODX insiders and whales buy or sell their stock.

CODX Shareholders

What type of owners hold Co Diagnostics Inc stock?
Brent Satterfield7.52%2,275,000$2.37MInsider
America 2030 Capital LLC7.50%2,269,795$2.36MInsider
Vanguard Group Inc5.89%1,781,283$1.85MInstitution
Reagents LLC5.77%1,746,796$1.82MInsider
Legends Capital Group LLC4.30%1,300,344$1.35MInsider
Renaissance Technologies LLC2.14%648,300$674.23kInstitution
Morgan Stanley1.72%521,238$542.09kInstitution
Blackrock Inc1.66%501,607$521.67kInstitution
Bridgeway Capital Management LLC1.14%345,900$359.74kInstitution
Geode Capital Management LLC1.06%319,494$332.27kInstitution

1 of 3

CODX vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CODX17.96%26.98%Net SellingNet Selling
AKU15.55%23.37%Net Buying
PMD24.43%49.51%Net SellingNet Selling

Co Diagnostics Stock Ownership FAQ

Who owns Co Diagnostics?

Co Diagnostics (NASDAQ: CODX) is owned by 17.96% institutional shareholders, 26.98% Co Diagnostics insiders, and 55.06% retail investors. Brent Satterfield is the largest individual Co Diagnostics shareholder, owning 2.28M shares representing 7.52% of the company. Brent Satterfield's Co Diagnostics shares are currently valued at $2.43M.

If you're new to stock investing, here's how to buy Co Diagnostics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.